The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Biogen Idec to Present at the 2013 RBC Capital Markets Global Healthcare Conference

Wednesday, February 20, 2013

Biogen Idec to Present at the 2013 RBC Capital Markets Global Healthcare Conference16:01 EST Wednesday, February 20, 2013 WESTON, Mass. (Business Wire) -- Biogen Idec Inc. (NASDAQ: BIIB) announced today that it will present at the 2013 RBC Capital Markets Global Healthcare Conference. The webcast will be live on Tuesday, February 26, 2013 at 9:30 a.m. ET. To access the live webcast, please visit Biogen Idec's Investors section at www.biogenidec.com. An archived version of the webcast will be available for 14 days following the presentation. About Biogen IdecThrough cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $5 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com. Investor RelationsBiogen IdecKaren Jewell, 781-464-2442